Valuation: Almirall, S.A.

Market Cap 2.36B 2.73B 2.2B 2.02B 3.8B 260B 3.86B 25.86B 10.15B 130B 10.25B 10.02B 430B P/E 2026 *
27.5x
P/E 2027 * 19.8x
Enterprise Value 2.25B 2.6B 2.1B 1.93B 3.63B 248B 3.68B 24.65B 9.68B 124B 9.77B 9.55B 410B EV / Sales 2026 *
1.83x
EV / Sales 2027 * 1.55x
Free-Float
35.93%
Yield 2026 *
1.87%
Yield 2027 * 1.94%
1 day-0.65%
1 week-1.64%
Current month-2.88%
1 month-4.09%
3 months-7.39%
6 months-18.83%
Current year-16.04%
1 week 10.76
Extreme 10.76
11.06
1 month 10.52
Extreme 10.52
11.96
Current year 10.52
Extreme 10.52
13.98
1 year 10.26
Extreme 10.26
13.98
3 years 7.85
Extreme 7.85
13.98
5 years 7.16
Extreme 7.16
14.96
10 years 7.16
Extreme 7.16
18.5
Manager TitleAgeSince
Chief Executive Officer - 2022-11-01
Director of Finance/CFO 53 2025-08-30
Chief Tech/Sci/R&D Officer - 2021-07-06
Director TitleAgeSince
Director/Board Member - 2013-12-31
Director/Board Member - 2015-12-31
Chairman - 2022-05-05
Date Insider Type Main position Quantity % Market Cap.
6/23/23 Buy

Executive/Senior Manager

3,000 0.0017%
6/22/23 Buy 4,340 0.0024%
6/22/23 Buy

Executive/Senior Manager

5,000 0.0028%
Change 5-day change 1-year change 3-year change Capi.($)
-0.65%-1.64%+3.45%+18.07% 2.73B
-0.52%+3.21%+89.52%+125.32% 1,057B
+0.88%+1.13%+49.56%+49.79% 625B
+0.89%-1.95%+24.23%+63.19% 435B
+1.24%+4.21%+50.63%+39.00% 363B
+0.46%+1.53%+31.64%+39.55% 296B
+0.40%+3.69%+8.05%+6.83% 249B
+1.51%+6.69%+42.58%+58.47% 222B
-0.07%+0.50%-5.83%-51.31% 209B
+1.80%+2.30%+11.56%+66.16% 165B
Average -0.01%+0.61%+30.54%+41.51% 362.35B
Weighted average by Cap. +0.18%+1.33%+48.58%+63.99%

Financials

2026 *2027 *
Net sales 1.23B 1.42B 1.15B 1.05B 1.98B 135B 2.01B 13.47B 5.29B 67.81B 5.34B 5.22B 224B 1.36B 1.57B 1.27B 1.16B 2.19B 149B 2.22B 14.86B 5.83B 74.8B 5.89B 5.76B 247B
Net income 84.14M 97.27M 78.58M 72.08M 136M 9.26B 138M 922M 362M 4.64B 365M 357M 15.34B 116M 135M 109M 99.7M 188M 12.8B 190M 1.28B 500M 6.42B 505M 494M 21.22B
Net Debt -111M -128M -103M -94.68M -178M -12.16B -181M -1.21B -475M -6.1B -480M -469M -20.15B -255M -295M -238M -219M -411M -28.06B -418M -2.79B -1.1B -14.07B -1.11B -1.08B -46.5B
Logo Almirall, S.A.
Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The Company's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The Company operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.
Employees
2,097
Date Price Change Volume
26-08-10 10.76 -0.74% 32,985
26-08-07 €10.84 -1.28% 118,274
26-08-06 €10.98 +0.37% 69,240
26-08-05 €10.94 -0.18% 109,376
26-08-04 €10.96 0.00% 142,833
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
10.84EUR
Average target price
14.51EUR
Spread / Average Target
+33.84%

Quarterly revenue - Rate of surprise